Skip to main content
Top
Published in: Clinical Journal of Gastroenterology 3/2020

01-06-2020 | Computed Tomography | Case Report

Isolated cardiac metastases of hepatocellular carcinoma after resection: a case report

Authors: Yosuke Tamura, Tomokazu Kawaoka, Hiroshi Aikata, Maiko Namba, Yasutomo Fujii, Kei Morio, Eisuke Murakami, Masami Yamauchi, Akira Hiramatsu, Takashi Nakahara, Michio Imamura, Tatsuya Maruhashi, Tsuyoshi Kobayashi, Hideki Ohdan, Tomoki Kimura, Yasushi Nagata, Kouji Arihiro, Kazuaki Chayama

Published in: Clinical Journal of Gastroenterology | Issue 3/2020

Login to get access

Abstract

A 76-year-old man was diagnosed with multiple hepatocellular carcinomas (HCCs). He underwent right lobectomy and partial resection of the liver after transcatheter arterial embolization at our hospital. The pathology report was moderately differentiated HCC (fT4N0M0 Stage Iva, Vp1, Vv0). Follow-up CT revealed a lesion in the right ventricle 3 years after surgery. Moderately differentiated HCC was determined on myocardial biopsy, and the lesion was diagnosed as cardiac metastasis of HCC. No recurrence of HCC was observed in the liver. Radiation therapy (39 Gy/13 fr) was performed for the cardiac metastasis, and oral lenvatinib 8 mg/day was started. Evaluation by mRECIST on contrast-enhanced CT indicate a partial response (PR). Lenvatinib has been continued for 7 months. Cardiac metastasis of HCC is extremely rare; herein, we have also provided a literature reviews.
Literature
1.
go back to reference Sabzi F, Heidari A, Faraji R. Isolated right atrial mass in a candidate of coronary bypasss grafting. Acta Med Iran. 2017;55(11):722–5.PubMed Sabzi F, Heidari A, Faraji R. Isolated right atrial mass in a candidate of coronary bypasss grafting. Acta Med Iran. 2017;55(11):722–5.PubMed
2.
go back to reference Takaya H, Kawaratani H, Seki K, et al. A patient with hepatocellular carcinoma with isolated right atrial metastases. Intern Med. 2017;56(19):2589–94.CrossRefPubMedPubMedCentral Takaya H, Kawaratani H, Seki K, et al. A patient with hepatocellular carcinoma with isolated right atrial metastases. Intern Med. 2017;56(19):2589–94.CrossRefPubMedPubMedCentral
3.
go back to reference Kim SB, Shin YC, Kwon SU. Isolated metastasis of hepatocellular carcinoma in the right ventricle: a case report. Medicine. 2016;95:51. Kim SB, Shin YC, Kwon SU. Isolated metastasis of hepatocellular carcinoma in the right ventricle: a case report. Medicine. 2016;95:51.
4.
go back to reference Kan CB, Chang RY, Chen CK. Isolated right ventricular intracavitary metastasis of hepatocellular carcinoma in a 74-year-old woman. J Chin Med Assoc. 2008;71(6):318–20.CrossRefPubMed Kan CB, Chang RY, Chen CK. Isolated right ventricular intracavitary metastasis of hepatocellular carcinoma in a 74-year-old woman. J Chin Med Assoc. 2008;71(6):318–20.CrossRefPubMed
5.
go back to reference Sekine Y, Kitano M, Akimoto T, Matsuda K. Isolated intracavitary metastatic hepatocellular carcinoma of the right atrium without inferior vena cava involvement; report of a case. Kyobu Geka. 2007;60(6):504–7 (in Japanese).PubMed Sekine Y, Kitano M, Akimoto T, Matsuda K. Isolated intracavitary metastatic hepatocellular carcinoma of the right atrium without inferior vena cava involvement; report of a case. Kyobu Geka. 2007;60(6):504–7 (in Japanese).PubMed
6.
go back to reference Chieng SH, Lin CH, Lu MJ, Hung CR. Intracavitary metastatic hepatocellular carcinoma of the right ventricle. Thorac Cardiovasc Surg. 2005;53(2):123–5.CrossRefPubMed Chieng SH, Lin CH, Lu MJ, Hung CR. Intracavitary metastatic hepatocellular carcinoma of the right ventricle. Thorac Cardiovasc Surg. 2005;53(2):123–5.CrossRefPubMed
7.
go back to reference Lei HM, Ko YL, Kuan P, Lien WP, Chen DS. Metastasis of hepatocellular carcinoma to the heart: unusual patterns in three cases with antemortem diagnosis. J Formos Med Assoc. 1992;91(4):457–61.PubMed Lei HM, Ko YL, Kuan P, Lien WP, Chen DS. Metastasis of hepatocellular carcinoma to the heart: unusual patterns in three cases with antemortem diagnosis. J Formos Med Assoc. 1992;91(4):457–61.PubMed
8.
go back to reference Kudo M, Finn RS, Qin S, et al. Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial. Lancet. 2018;391:1163–73.CrossRefPubMed Kudo M, Finn RS, Qin S, et al. Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial. Lancet. 2018;391:1163–73.CrossRefPubMed
9.
go back to reference Tsukamoto T, Onishi N, Hamabe Y, et al. Isolated right ventricular hepatocellular carcinoma metastasis. Jpn Coll Surg. 2009;34(5):899–904 (in Japanese).CrossRef Tsukamoto T, Onishi N, Hamabe Y, et al. Isolated right ventricular hepatocellular carcinoma metastasis. Jpn Coll Surg. 2009;34(5):899–904 (in Japanese).CrossRef
10.
go back to reference Tastekin E, Usta U, Ege T, et al. Cardiac metastasis of hepatocellular carcinoma in a young non-cirrhotic patient, to the left ventricle. Ann Hepatol. 2012;11(3):392–4.CrossRefPubMed Tastekin E, Usta U, Ege T, et al. Cardiac metastasis of hepatocellular carcinoma in a young non-cirrhotic patient, to the left ventricle. Ann Hepatol. 2012;11(3):392–4.CrossRefPubMed
11.
go back to reference Kojiro M, Nakahara H, Sugihara S, Murakami T, Nakashima T, Kawasaki H. Hepatocellular carcinoma with intra-atrial tumor growth. A clinicopathologic study of 18 autopsy cases. Arch Pathol Lab Med. 1984;108:989–92.PubMed Kojiro M, Nakahara H, Sugihara S, Murakami T, Nakashima T, Kawasaki H. Hepatocellular carcinoma with intra-atrial tumor growth. A clinicopathologic study of 18 autopsy cases. Arch Pathol Lab Med. 1984;108:989–92.PubMed
12.
go back to reference MacDonald RA. Primary carcinoma of the liver; a clinicopathologic study of one hundred eight cases. AMA Arch Intern Med. 1957;99:266–79.CrossRefPubMed MacDonald RA. Primary carcinoma of the liver; a clinicopathologic study of one hundred eight cases. AMA Arch Intern Med. 1957;99:266–79.CrossRefPubMed
13.
go back to reference Kotani E, Kiuchi K, Takayama M. Effectiveness of transcoronary chemoembolization for metastatic right ventricular tumor derived from hepatocellular carcinoma. Chest. 2000;117:287–9.CrossRefPubMed Kotani E, Kiuchi K, Takayama M. Effectiveness of transcoronary chemoembolization for metastatic right ventricular tumor derived from hepatocellular carcinoma. Chest. 2000;117:287–9.CrossRefPubMed
14.
go back to reference Minami T, Ishii T, Hatano E, et al. A case of cardiac and pulmonary metastasis of hepatocellular carcinoma with no recurrence for seven years after a radical operation. Jpn J Clin Surg. 2013;74(10):2875–8 (in Japanese). Minami T, Ishii T, Hatano E, et al. A case of cardiac and pulmonary metastasis of hepatocellular carcinoma with no recurrence for seven years after a radical operation. Jpn J Clin Surg. 2013;74(10):2875–8 (in Japanese).
15.
go back to reference Sachin HS, Preethi S, Pramesh CS, et al. Asymptomatic cardiac metastasis in a diagnosed case of squamous cell carcinoma of the middle third of esophagus. Indian J Palliat Care. 2018;24(3):365–8.PubMedPubMedCentral Sachin HS, Preethi S, Pramesh CS, et al. Asymptomatic cardiac metastasis in a diagnosed case of squamous cell carcinoma of the middle third of esophagus. Indian J Palliat Care. 2018;24(3):365–8.PubMedPubMedCentral
16.
go back to reference Zaakook M, Ayoub M, Sinna EA, El-Sheikh S. Role of glypican-3 immunocytochemistry in differentiating hepatocellular carcinoma from metastatic carcinoma of the liver utilizing fine needle aspiration cytology. J Egypt Natl Canc Inst. 2013;25(4):173–80.CrossRefPubMed Zaakook M, Ayoub M, Sinna EA, El-Sheikh S. Role of glypican-3 immunocytochemistry in differentiating hepatocellular carcinoma from metastatic carcinoma of the liver utilizing fine needle aspiration cytology. J Egypt Natl Canc Inst. 2013;25(4):173–80.CrossRefPubMed
17.
go back to reference Kawaoka T, Aikata H, Chayama K, et al. Evaluation of mRECIST and α-fetoprotein ratio for stratification of the prognosis of advanced-hepatocellular carcinoma patients treated with sorafenib. Oncology. 2012;83:192–200.CrossRefPubMed Kawaoka T, Aikata H, Chayama K, et al. Evaluation of mRECIST and α-fetoprotein ratio for stratification of the prognosis of advanced-hepatocellular carcinoma patients treated with sorafenib. Oncology. 2012;83:192–200.CrossRefPubMed
18.
go back to reference Kawakami M, Koda M, Mandai M, et al. Isolated metastases of hepatocellular carcinoma in the right atrium: case report and review of the literature. Oncol Left. 2013;5(5):1505–8.CrossRef Kawakami M, Koda M, Mandai M, et al. Isolated metastases of hepatocellular carcinoma in the right atrium: case report and review of the literature. Oncol Left. 2013;5(5):1505–8.CrossRef
19.
go back to reference Shiota S, Konishi I, Sato N, et al. A case of hepatocellular carcinoma with metastases to the right ventricle of the heart. Jpn J Clin Surg. 2000;61(6):1542–6 (in Japanese). Shiota S, Konishi I, Sato N, et al. A case of hepatocellular carcinoma with metastases to the right ventricle of the heart. Jpn J Clin Surg. 2000;61(6):1542–6 (in Japanese).
Metadata
Title
Isolated cardiac metastases of hepatocellular carcinoma after resection: a case report
Authors
Yosuke Tamura
Tomokazu Kawaoka
Hiroshi Aikata
Maiko Namba
Yasutomo Fujii
Kei Morio
Eisuke Murakami
Masami Yamauchi
Akira Hiramatsu
Takashi Nakahara
Michio Imamura
Tatsuya Maruhashi
Tsuyoshi Kobayashi
Hideki Ohdan
Tomoki Kimura
Yasushi Nagata
Kouji Arihiro
Kazuaki Chayama
Publication date
01-06-2020
Publisher
Springer Singapore
Published in
Clinical Journal of Gastroenterology / Issue 3/2020
Print ISSN: 1865-7257
Electronic ISSN: 1865-7265
DOI
https://doi.org/10.1007/s12328-019-01075-6

Other articles of this Issue 3/2020

Clinical Journal of Gastroenterology 3/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.